EDGAR Filing Documents for 0001193125-23-213683

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-23-213683

Filing Date

2023-08-16

Accepted

2023-08-15 21:40:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d543736ds3.htm	S-3	204859
2	EX-5.1	d543736dex51.htm	EX-5.1	11803
3	EX-23.1	d543736dex231.htm	EX-23.1	1672
4	EX-FILING FEES	d543736dexfilingfees.htm	EX-FILING FEES	22182
5	GRAPHIC	g543736g06v39.jpg	GRAPHIC	11294
6	GRAPHIC	g543736g0815145625831.jpg	GRAPHIC	1843
7	GRAPHIC	g543736g15w44.jpg	GRAPHIC	41750
	Complete submission text file	0001193125-23-213683.txt		307827

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274010 | Film No.: 231176371
SIC: 2834 Pharmaceutical Preparations